Aggregation

Strategies and best practices for aggregating diverse pharmaceutical data sources into unified, analyzable, and reproducible datasets.

  2 minute read  

Aggregation Strategies Come in Many Shapes and Sizes#

Once data has been collected, it often exists in a variety of formats—PDFs, CSVs, Excel files, databases, and more. The challenge is to bring this disparate information together in a way that enables meaningful analysis, supports decision-making, and maintains data integrity.

Aggregation is not a one-size-fits-all process. The optimal strategy depends on your goals, available resources, and the complexity of your data landscape. The focus should always be on fit-for-purpose approaches that optimize speed, cost, and quality.

Key Considerations for Data Aggregation#

  • Conformance to a Common Data Model: Standardizing data into a unified structure is essential for downstream analytics, regulatory submissions, and reproducibility.
  • Data Cleaning and Transformation: Raw data often requires cleaning, normalization, and transformation to ensure consistency and usability.
  • Automation vs. Manual Integration: Automated pipelines can accelerate aggregation and reduce errors, but manual curation may be necessary for complex or legacy datasets.
  • Documentation and Traceability: Every step in the aggregation process should be well-documented to ensure transparency and reproducibility.

Recipe-Based Approach#

Our recommended strategy is to follow a recipe-based approach, which provides a structured, repeatable method for aggregating and transforming data. This approach emphasizes modularity, transparency, and adaptability—key principles for robust data management in pharmaceutical research and manufacturing.

For a detailed discussion and practical examples, see the following paper:


Last modified July 7, 2025: Enhance documentation for Design, Data Collection, and Aggregation sections, improving clarity and adding key considerations for effective pharmaceutical research practices. (a9d08ba)